Enzo Biochem (ENZ) Stock Chart & Stock Price History → Wall Street Icon: 'I'd Put 50% of My Kids' Inheritance in THIS stock' (From Stansberry Research) (Ad) Free ENZ Stock Alerts $1.19 +0.03 (+2.59%) (As of 06/11/2024 ET) Add Compare Share Share ChartStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Enzo Biochem Stock Price Performance5 Day Performance+0.85%1 Month Performance+14.42%3 Month Performance-9.51%6 Month Performance-4.80%Year-To-Date Performance-14.39%1 Year Performance-45.41% Receive ENZ Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Enzo Biochem and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Weiss Ratings[URGENT] DO NOT Touch These AI Stocks!Artificial intelligence stocks are carrying the market. One of them, Nvidia, recently became the seventh company ever to hit a $1 trillion market cap. But is this AI rally over?Click here for our #1 AI Stock for 2024 and Beyond ENZ Stock Chart for Wednesday, June, 12, 2024 ENZ Chart by TradingView Enzo Biochem Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization06/11/2024$1.18$1.19+0.85%$1.19$1.1343,040 shs$60.96 million06/10/2024$1.13$1.18+4.42%$1.18$1.1084,185 shs$60.45 million06/07/2024$1.18$1.13-4.24%$1.18$1.1276,071 shs$57.89 million06/06/2024$1.16$1.18+1.72%$1.19$1.1719,229 shs$60.45 million06/05/2024$1.15$1.16+0.87%$1.17$1.1239,107 shs$59.43 million06/04/2024$1.20$1.15-4.17%$1.23$1.11112,998 shs$58.91 million Get the Latest News and Ratings for ENZ and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Enzo Biochem and its competitors with MarketBeat's FREE daily newsletter. 06/03/2024$1.19$1.20+0.84%$1.24$1.14138,410 shs$61.48 million05/31/2024$1.18$1.19+0.85%$1.23$1.1382,342 shs$60.96 million05/30/2024$1.25$1.18-5.60%$1.25$1.13338,227 shs$60.45 million05/29/2024$1.18$1.25+5.93%$1.28$1.17282,079 shs$64.04 million05/28/2024$1.07$1.18+10.28%$1.20$1.08388,608 shs$60.45 million05/27/2024$1.07$1.07$1.08$1.0350,500 shs$54.81 million05/24/2024$1.05$1.07+1.90%$1.08$1.0326,821 shs$54.82 million05/23/2024$1.06$1.05-0.94%$1.09$1.05116,502 shs$53.79 million05/22/2024$1.05$1.06+0.95%$1.07$1.03228,400 shs$54.30 million05/21/2024$1.11$1.05-5.41%$1.11$1.0560,743 shs$53.79 million05/20/2024$1.09$1.11+1.83%$1.13$1.0842,387 shs$56.87 million05/17/2024$1.11$1.09-1.80%$1.13$1.0731,340 shs$55.84 million05/16/2024$1.10$1.11+0.91%$1.14$1.10104,991 shs$56.87 million05/15/2024$1.09$1.10+0.92%$1.11$1.0648,390 shs$56.35 million05/14/2024$1.09$1.09$1.12$1.0681,861 shs$55.84 million05/13/2024$1.04$1.09+4.81%$1.12$1.06255,765 shs$55.84 million05/10/2024$1.04$1.03-0.96%$1.06$1.0379,084 shs$52.76 million05/09/2024$1.12$1.04-7.14%$1.13$1.04133,852 shs$53.28 million05/08/2024$1.09$1.12+2.75%$1.12$1.0792,712 shs$57.37 million05/07/2024$1.09$1.09$1.12$1.0782,967 shs$55.84 million05/06/2024$1.04$1.09+4.81%$1.09$1.00291,554 shs$55.84 million05/03/2024$1.04$1.04$1.08$1.0373,101 shs$53.28 million05/02/2024$1.04$1.04$1.06$1.0346,475 shs$53.28 million05/01/2024$1.05$1.04-0.95%$1.05$1.0349,963 shs$53.28 million04/30/2024$1.06$1.05-0.94%$1.06$1.0189,663 shs$53.79 million04/29/2024$1.05$1.06+0.95%$1.08$1.0532,458 shs$54.30 million04/26/2024$1.08$1.05-2.78%$1.07$1.04114,913 shs$53.79 million04/25/2024$1.06$1.08+1.89%$1.08$1.0474,257 shs$55.33 million04/24/2024$1.10$1.06-3.64%$1.09$1.0577,036 shs$54.30 million04/23/2024$1.09$1.10+0.92%$1.11$1.0875,501 shs$56.35 million04/22/2024$1.09$1.09$1.11$1.07120,187 shs$55.84 million04/19/2024$1.12$1.08-3.57%$1.12$1.07256,550 shs$55.32 million04/18/2024$1.15$1.12-2.61%$1.14$1.08203,077 shs$57.38 million04/17/2024$1.15$1.15$1.16$1.13123,978 shs$58.91 millionBill Clinton Backing Biden Replacement??? (Ad)Louis Navellier — a frequent guest at Mar-a-Lago — ruffled many in his own circles when he declared over a year ago that Trump’s conviction was already a foregone conclusion. But his prediction on Biden was, if anything, more surprising.This shocking video reveals exactly how.04/16/2024$1.16$1.15-0.86%$1.17$1.1552,768 shs$58.91 million04/15/2024$1.17$1.16-0.85%$1.20$1.16117,278 shs$59.43 million04/12/2024$1.18$1.17-0.85%$1.20$1.16103,240 shs$59.94 million04/11/2024$1.24$1.18-4.84%$1.24$1.17152,832 shs$60.45 million04/10/2024$1.20$1.24+3.33%$1.24$1.17135,416 shs$63.53 million04/09/2024$1.19$1.20+0.84%$1.21$1.1787,142 shs$61.48 million04/08/2024$1.26$1.19-5.56%$1.28$1.17321,777 shs$60.96 million04/05/2024$1.27$1.25-1.57%$1.29$1.2548,052 shs$64.03 million04/04/2024$1.27$1.27$1.29$1.2623,539 shs$65.06 million04/03/2024$1.28$1.27-0.78%$1.29$1.2629,292 shs$65.06 million04/02/2024$1.27$1.28+1.19%$1.29$1.2542,924 shs$65.57 million04/01/2024$1.27$1.27-0.39%$1.29$1.2538,320 shs$64.81 million03/29/2024$1.27$1.27$1.29$1.2745,472 shs$65.06 million03/28/2024$1.26$1.27+0.79%$1.29$1.2745,471 shs$65.06 million03/27/2024$1.25$1.26+0.80%$1.30$1.2387,046 shs$64.55 million03/26/2024$1.25$1.25$1.27$1.2388,262 shs$64.04 million03/25/2024$1.26$1.25-0.79%$1.27$1.2541,684 shs$64.04 million03/22/2024$1.23$1.25+1.63%$1.25$1.2172,168 shs$63.78 million03/21/2024$1.22$1.23+0.41%$1.26$1.22129,008 shs$62.76 million03/20/2024$1.23$1.22-0.81%$1.28$1.22110,710 shs$62.50 million03/19/2024$1.26$1.23-2.38%$1.29$1.2242,604 shs$63.01 million03/18/2024$1.21$1.26+4.13%$1.29$1.2178,039 shs$64.55 million03/15/2024$1.26$1.23-2.38%$1.30$1.21153,977 shs$62.10 million03/14/2024$1.25$1.26+1.20%$1.32$1.25252,908 shs$63.62 million03/13/2024$1.27$1.25-1.97%$1.30$1.2460,501 shs$62.86 million03/12/2024$1.32$1.27-3.42%$1.31$1.27105,566 shs$64.12 million03/11/2024$1.33$1.32-1.13%$1.33$1.3061,059 shs$66.39 million Related Companies: Biodesix Stock Chart Burning Rock Biotech Stock Chart Personalis Stock Chart Exagen Stock Chart Renalytix Stock Chart Psychemedics Stock Chart DermTech Stock Chart BioNexus Gene Lab Stock Chart OpGen Stock Chart Fresh2 Group Stock Chart Receive ENZ Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Enzo Biochem and its competitors with MarketBeat's FREE daily newsletter. This page (NYSE:ENZ) was last updated on 6/12/2024 by MarketBeat.com Staff From Our PartnersYour Special Report - Top 7 Summer StocksSummer is almost Here! I would like to give you a special report that could help boost your portfolio this sum...StockEarnings | SponsoredThe Hidden Tax Advantages of America’s #1 Inheritance StockWall Street Millionaire: BUY "America's #1 Legacy Stock" The man CNBC called "The Prophet" bought AAPL at $...Stansberry Research | SponsoredBill Clinton Backing Biden Replacement???Louis Navellier — a frequent guest at Mar-a-Lago — ruffled many in his own circles when he declared over a yea...The Freeport Society | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | SponsoredNo Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for FreeOptimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analys...Hedgeye | SponsoredHurry! Buy this stock before the Robinhood traders do!Robinhood traders have piled $78 billion into this market... Driving tiny tech stock gains of 3,000%, 8,942...Traders Agency | SponsoredAI's Next Magnificent SevenThe Original Magnificent Seven Produced 16,894% Average Returns Over 20 Years.The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Enzo Biochem, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Enzo Biochem With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.